Business Description
Lixte Biotechnology Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US5393191037
Description
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.81 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 2.9 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -5.9 | |||||
| 3-Year Book Growth Rate | -43.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 87.82 | |||||
| 9-Day RSI | 74.95 | |||||
| 14-Day RSI | 66.48 | |||||
| 6-1 Month Momentum % | -8.75 | |||||
| 12-1 Month Momentum % | -20.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.13 | |||||
| Quick Ratio | 5.13 | |||||
| Cash Ratio | 4.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -127.74 | |||||
| ROA % | -114.31 | |||||
| ROIC % | -1959.19 | |||||
| ROCE % | -127.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.73 | |||||
| EV-to-EBITDA | -1.73 | |||||
| EV-to-FCF | -1.98 | |||||
| Price-to-Net-Cash | 3.84 | |||||
| Earnings Yield (Greenblatt) % | -57.8 | |||||
| FCF Yield % | -69.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LIXT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Lixte Biotechnology Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.73 | ||
| Beta | 0.67 | ||
| Volatility % | 54.84 | ||
| 14-Day RSI | 66.48 | ||
| 14-Day ATR ($) | 0.220484 | ||
| 20-Day SMA ($) | 1.772 | ||
| 12-1 Month Momentum % | -20.31 | ||
| 52-Week Range ($) | 1.31 - 4.4 | ||
| Shares Outstanding (Mil) | 2.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lixte Biotechnology Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lixte Biotechnology Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lixte Biotechnology Holdings Inc Frequently Asked Questions
What is Lixte Biotechnology Holdings Inc(LIXT)'s stock price today?
The current price of LIXT is $2.23. The 52 week high of LIXT is $4.40 and 52 week low is $1.31.
When is next earnings date of Lixte Biotechnology Holdings Inc(LIXT)?
The next earnings date of Lixte Biotechnology Holdings Inc(LIXT) is 2025-02-12 Est..
Does Lixte Biotechnology Holdings Inc(LIXT) pay dividends? If so, how much?
Lixte Biotechnology Holdings Inc(LIXT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers